Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
Moira Verbelen, Michael E Weale, Cathryn M Lewis
This study reviews economic evaluations of pharmacogenetic-guided treatments and finds that cost-effectiveness improves significantly if genetic testing is free.
bioRxiv · Jul 23, 2016Genetics